Cite
HARVARD Citation
Alexander, G. et al. (2015). Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].